BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33193373)

  • 1. A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.
    Xue YN; Xue YN; Wang ZC; Mo YZ; Wang PY; Tan WQ
    Front Immunol; 2020; 11():576914. PubMed ID: 33193373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
    Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
    Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
    Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
    J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy.
    Wu X; Wang X; Zhao Y; Li K; Yu B; Zhang J
    Int J Med Sci; 2021; 18(7):1657-1669. PubMed ID: 33746582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma.
    Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M
    PeerJ; 2022; 10():e12646. PubMed ID: 35116193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
    Han W; Huang B; Zhao XY; Shen GL
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
    Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
    Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
    Yan K; Wang Y; Lu Y; Yan Z
    J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.